94 related articles for article (PubMed ID: 1871941)
1. [Local hyperthermia in prostate cancer].
Bichler KH; Strohmaier WL; Flüchter SH; Nelde HJ; Wilbert DM
Urologe A; 1991 May; 30(3):196-203. PubMed ID: 1871941
[TBL] [Abstract][Full Text] [Related]
2. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma.
Algan O; Fosmire H; Hynynen K; Dalkin B; Cui H; Drach G; Stea B; Cassady JR
Cancer; 2000 Jul; 89(2):399-403. PubMed ID: 10918172
[TBL] [Abstract][Full Text] [Related]
3. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0.
Tilly W; Gellermann J; Graf R; Hildebrandt B; Weissbach L; Budach V; Felix R; Wust P
Strahlenther Onkol; 2005 Jan; 181(1):35-41. PubMed ID: 15660191
[TBL] [Abstract][Full Text] [Related]
4. [Radiation exposure and local hyperthermia in the treatment of prostatic cancer].
Goldobenko GV; Tkachev SI; Matveev BP; Aliev BM; Bukharkin BV; Zhmarkin NI
Urol Nefrol (Mosk); 1990; (4):35-8. PubMed ID: 2125765
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer.
Pummer K; Lehnert M; Stettner H; Hubmer G
Eur Urol; 1997; 32 Suppl 3():81-5. PubMed ID: 9267791
[TBL] [Abstract][Full Text] [Related]
6. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia.
Van Vulpen M; De Leeuw JR; Van Gellekom MP; Van Der Hoeven J; De Graeff A; Van Moorselaar RJ; Van Der Tweel I; Hofman P; Lagendijk JJ; Battermann JJ
Int J Hyperthermia; 2003; 19(4):402-13. PubMed ID: 12850926
[TBL] [Abstract][Full Text] [Related]
7. Review. Current role and future perspectives of hyperthermia for prostate cancer treatment.
Baronzio G; Gramaglia A; Fiorentini G
In Vivo; 2009; 23(1):143-6. PubMed ID: 19368139
[TBL] [Abstract][Full Text] [Related]
8. Are monotherapy options reasonable for T3 prostate cancer?
Schellhammer PF; Lynch DF
Semin Urol Oncol; 1997 Nov; 15(4):207-14. PubMed ID: 9421447
[TBL] [Abstract][Full Text] [Related]
9. Prognostic markers in clinically localized prostate cancer.
Pettaway CA
Tech Urol; 1998 Mar; 4(1):35-42. PubMed ID: 9568775
[TBL] [Abstract][Full Text] [Related]
10. Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study.
Maluta S; Dall'Oglio S; Romano M; Marciai N; Pioli F; Giri MG; Benecchi PL; Comunale L; Porcaro AB
Int J Hyperthermia; 2007 Aug; 23(5):451-6. PubMed ID: 17701536
[TBL] [Abstract][Full Text] [Related]
11. Thermoradiotherapy using interstitial self-regulating thermoseeds: an intermediate analysis of a phase II trial.
Deger S; Taymoorian K; Boehmer D; Schink T; Roigas J; Wille AH; Budach V; Wernecke KD; Loening SA
Eur Urol; 2004 May; 45(5):574-9; discussion 580. PubMed ID: 15082198
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
[TBL] [Abstract][Full Text] [Related]
13. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
[TBL] [Abstract][Full Text] [Related]
14. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
[TBL] [Abstract][Full Text] [Related]
15. Does local hyperthermia affect metastasis of a human prostate carcinoma grown in athymic nude mice?
Greenstein A; Koontz WW
Int J Hyperthermia; 2002; 18(4):285-91. PubMed ID: 12079584
[TBL] [Abstract][Full Text] [Related]
16. [Studies of progressive factors of stage A prostatic cancer].
Suzuki T; Shimizu T; Imai K; Yamanaka H; Suzuki K; Takahashi H
Hinyokika Kiyo; 1989 Feb; 35(2):259-63. PubMed ID: 2735237
[TBL] [Abstract][Full Text] [Related]
17. Histological effects of local microwave hyperthermia in prostatic cancer.
Strohmaier WL; Bichler KH; Böcking A; Flüchter SH
Int J Hyperthermia; 1991; 7(1):27-33. PubMed ID: 2051074
[TBL] [Abstract][Full Text] [Related]
18. [Transrectal prostatosonography. Follow-up in prostate cancer therapy].
Dolz M; Drakopoulos A; Aurich B; Frentzel-Beyme B
Z Urol Nephrol; 1985 Sep; 78(9):465-74. PubMed ID: 3907200
[TBL] [Abstract][Full Text] [Related]
19. [A case of small cell carcinoma of the prostate].
Murao T; Tanahashi T
Gan No Rinsho; 1988 Sep; 34(11):1624-8. PubMed ID: 2846913
[TBL] [Abstract][Full Text] [Related]
20. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
Strnad V; Geiger M; Lotter M; Sauer R
Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
